4.2 Article

A Novel Titin Truncation Variant Linked to Familial Dilated Cardiomyopathy Found in a Japanese Family and Its Functional Analysis in Genome-Edited Model Cells

Journal

INTERNATIONAL HEART JOURNAL
Volume 62, Issue 2, Pages 359-366

Publisher

INT HEART JOURNAL ASSOC
DOI: 10.1536/ihj.20-664

Keywords

Genome editing; Heart failure

Funding

  1. Japan Society for the Promotion of Science KAKENHI [26460407, 17K08684, 15K15095, 16H05296]
  2. Japan Society for the Promotion of Science, Nanken-Kyoten
  3. Tokyo Medical and Dental University (TMDU)
  4. Tokai University School of Medicine
  5. Japan Agency for Medical Research and Development (AMED) [JA19ek0109292]
  6. Grants-in-Aid for Scientific Research [16H05296, 17K08684, 15K15095] Funding Source: KAKEN

Ask authors/readers for more resources

Heart failure is a life-threatening disease often caused by cardiomyopathy, with dilated cardiomyopathy (DCM) being a common type characterized by ventricular enlargement and progressive heart failure. A novel pathogenic TTN truncation variant was discovered in familial DCM patients, and its functional changes were confirmed using a relatively simple cell model.
Dilated cardiomyopathy (DCM) is a common cause of heart failure. TTN, which encodes titin protein, is a representative causative gene of DCM, and is presented mainly as a truncation variant. However, TTN truncation variants are also found in healthy individuals, and it is therefore important to evaluate the pathogenicity of each variant. In this study, we analyzed 67 cardiomyopathy-associated genes in a male Japanese patient who was hospitalized for recurrent severe heart failure and identified a novel truncation variant, TTN Ser17456Arg fs*14. This TTN truncation variant was located in the A-band region. Moreover, the patient?s mother with heart failure harbored the same variant, whereas the father and brother without heart failure did not harbor the variant. To examine the functional changes associated with the truncation variant, H9c2 cells were subjected to genome editing to generate cells with a homologous truncation variant. The cells were differentiated using all-trans-retinoic acid, and the mRNA expression of skeletal actin and cardiac actin were found to be increased and decreased, respectively, consistent with known changes in patients with DCM or heart failure. In contrast, another cell with the titin truncation variant used as a control showed no changes in heart failure-related genes. In summary, we found a novel TTN truncation variant in familial DCM patients and confirmed its functional changes using a relatively simple cell model. The novel truncation variant was identified as a pathogenic and disease-causing mutation. Heart failure is a life-threatening disease often caused by cardiomyopathy. Primary cardiomyopathy can be classified as dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, or left ventricular noncompaction (LVNC).1,2)DCM is characterized by ventricular enlargement and progressive heart failure with a prevalence of 1:

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available